When.com Web Search

  1. Ads

    related to: what is gadoteric acid supplement benefits for humans dosage

Search results

  1. Results From The WOW.Com Content Network
  2. Gadoteric acid - Wikipedia

    en.wikipedia.org/wiki/Gadoteric_acid

    Gadoteric acid, sold under the brand name Dotarem among others, is a macrocycle-structured gadolinium-based MRI contrast agent (GBCA). It consists of the organic acid DOTA as a chelating agent , and gadolinium (Gd 3+ ), and is used in form of the meglumine salt (gadoterate meglumine).

  3. Gadobutrol - Wikipedia

    en.wikipedia.org/wiki/Gadobutrol

    Gadobutrol contrast media is a clear, colorless-to-pale yellow solution of 1 mmol/mL formulation, available in single dose vials (2 mL, 7.5 mL, 10mL, and 15 mL), single dose pre-filled injections (7.5 mL, 10 mL, 15 mL), and pharmacy bulk packages (30 mL and 65 mL) containing multiple vials. [19]

  4. Gadoteridol - Wikipedia

    en.wikipedia.org/wiki/Gadoteridol

    This article about magnetic resonance imaging is a stub. You can help Wikipedia by expanding it.

  5. Gadoxetic acid - Wikipedia

    en.wikipedia.org/wiki/Gadoxetic_acid

    Gadoxetic acid is a gadolinium-based MRI contrast agent. [4] Its salt, gadoxetate disodium , is marketed as Primovist in Europe and Eovist in the United States by Bayer HealthCare Pharmaceuticals .

  6. DOTA (chelator) - Wikipedia

    en.wikipedia.org/wiki/DOTA_(chelator)

    DOTA is derived from the macrocycle known as cyclen.The four secondary amine groups are modified by replacement of the N-H centers with N-CH 2 CO 2 H groups. The resulting aminopolycarboxylic acid, upon ionization of the carboxylic acid groups, is a high affinity chelating agent for di- and trivalent cations.

  7. Gadopiclenol - Wikipedia

    en.wikipedia.org/wiki/Gadopiclenol

    Gadopiclenol was approved for medical use in the United States in September 2022 by the Food and Drug Administration. [2] [12]In October 2023, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Elucirem, intended for contrast-enhanced ...